Prognostic and Diagnostic Value of Endocan in Kidney Diseases

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="1"><hr/></td></tr><tr><td class="align_left"><b>Benefits</b></td></tr><tr><td class="align_left"> Soluble in human fluids</td></tr><tr><td class="align_left"> Having low concentration in physiological conditions</td></tr><tr><td class="align_left"> Easily measurable</td></tr><tr><td class="align_left"> Noninvasive</td></tr><tr><td class="align_left"> Multifunctional, associated with inflammation, endothelial injury, the decline of renal function, and/or incidence of cardiovascular events in several types of kidney disease</td></tr><tr><td class="align_left"><hr/></td></tr><tr><td class="align_left"><b>Limitations</b></td></tr><tr><td class="align_left"> Plasma elevation does not always correlate with kidney function deterioration</td></tr><tr><td class="align_left"> Several medications could influence its measurement</td></tr><tr><td class="align_left"> Large-scaled, multicentered clinical trials pend to define its applicability</td></tr><tr class="table-tr"><td colspan="1"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Benefits and limitations of endocan as a prognostic and diagnostic biomarker in kidney diseases.</div>

International Journal of Nephrology

Prognostic and Diagnostic Value of Endocan in Kidney Diseases

Table 1